Literature DB >> 15581673

Ovarian hormone withdrawal-induced "depression" in female rats.

Erin C Stoffel1, Rebecca M Craft.   

Abstract

Approximately 15% of child-bearing women develop postpartum depression (PPD), and many women with PPD experience anxious symptoms. It has been proposed that PPD is precipitated by the dramatic decline in reproductive hormones that occurs just after childbirth. To examine this hypothesis, ovariectomized female Sprague-Dawley rats underwent a hormone-simulated pregnancy (HSP) regimen; during the subsequent hormone withdrawal period, rats were tested in the forced swim test or elevated plus-maze, animal models of depression and anxiety, respectively. The HSP regimen consisted of injections with progesterone and escalating doses of estradiol benzoate for 22 days; control rats received daily vehicle injections. One, two, four or seven days after the last hormone injection, separate groups of rats were tested once on either the forced swim test or the elevated plus-maze. To examine any hormone withdrawal-induced changes in activity levels, spontaneous locomotor activity was measured at the same time points. At 2 and 4 days after the last hormone injection, HSP-treated females displayed significant increases in immobility relative to vehicle-treated females in the forced swim test. Behavior on the elevated plus-maze did not differ between the HSP and control groups at any of the withdrawal time points. There were also no differences in spontaneous locomotor activity between the HSP and control females at any of the withdrawal time points. The results of this study suggest that postpartum hormone withdrawal may contribute to depressive symptoms experienced after giving birth, and that the HSP-hormone withdrawal protocol may provide a useful animal model of PPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581673     DOI: 10.1016/j.physbeh.2004.08.033

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  45 in total

1.  Forced swim test behavior in postpartum rats.

Authors:  R M Craft; M L Kostick; J A Rogers; C L White; K T Tsutsui
Journal:  Pharmacol Biochem Behav       Date:  2010-07-01       Impact factor: 3.533

2.  Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

Authors:  Ethan H Beckley; Angela C Scibelli; Deborah A Finn
Journal:  Psychoneuroendocrinology       Date:  2010-12-15       Impact factor: 4.905

Review 3.  Sex differences and stress across the lifespan.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

4.  Parity and estrogen-administration alter affective behavior of ovariectomized rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Physiol Behav       Date:  2007-09-25

Review 5.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

Review 6.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

Review 7.  Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective.

Authors:  Michelle M Martel; Kelly Klump; Joel T Nigg; S Marc Breedlove; Cheryl L Sisk
Journal:  Horm Behav       Date:  2009-03-02       Impact factor: 3.587

Review 8.  Enduring influence of pubertal stressors on behavioral response to hormones in female mice.

Authors:  Jeffrey D Blaustein; Nafissa Ismail
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 9.  Using animal models to study post-partum psychiatric disorders.

Authors:  C V Perani; D A Slattery
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 10.  Maternally responsive neurons in the bed nucleus of the stria terminalis and medial preoptic area: Putative circuits for regulating anxiety and reward.

Authors:  Jenna A McHenry; David R Rubinow; Garret D Stuber
Journal:  Front Neuroendocrinol       Date:  2015-04-21       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.